PTEN and prostate carcinoma: As our data processing pipeline utilized data from prostate cancer, we first investigated the ability of this predicted PTEN ceRNA TNRC6B to modulate endogenous PTEN levels in several commonly used prostate cancer cell lines which express wild-type PTEN, DU145, 22rv1 and BM1604 (See Fig. 5).